Radiation Oncologist: Abhishek Solanki, MD | Loyola Medicine

Abhishek Solanki, MD

Radiation Oncology

Assistant Professor

Languages Spoken

English, Gujarati

Clinical Expertise

  • Acoustic Tumors
  • Bladder Cancer
  • Brain Tumor
  • Central Nervous System Malignancies (CNS)
  • HDR Prostate Brachytherapy
  • Kidney Cancer
  • LDR Prostate Seed Brachytherapy
  • Meningioma
  • Pituitary Tumor
  • Prostate Brachytherapy
  • Prostate Cancer
  • Prostate IMRT
  • Radiosurgery
  • Spinal Tumor
  • Spine Radiosurgery
  • Testicular Cancer

About Dr. Solanki

Interests
Swimming, Jogging, Photography, Family Time

Medical Education

Medical School
University of Chicago
Residency
University of Chicago Medical Center - Radiation Oncology
Fellowship

Board Certification

American Board of Radiology, Radiation Oncology

Research

  • Cranial Base Meningiomas Prabhu, V. C.; Melian, E.; Germanwala, A. V.; Solanki, A. A.; Borys, E.; Barton, K.; Anderson, D. E., World neurosurgery
  • Optimizing the Role of Surgery and Radiation Therapy in Urethral Cancer Based on Histology and Disease Extent. Son, CH; Liauw, SL; Hasan, Y; Solanki, AA, International journal of radiation oncology, biology, physics
  • Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017. Okunieff, P; Casey-Sawicki, K; Lockney, NA; Hoppe, BS; Enderling, H; Pinnix, C; Welsh, J; Krishnan, S; Yothers, G; Brown, M; Knox, S; Bristow, R; Spellman, P; Mitin, T; Nabavizadeh, N; Jaboin, J; Manning, HC; Feng, F; Galbraith, S; Solanki, AA; Harkenrider, MM; Tuli, R; Decker, RH; Finkelstein, SE; Hsu, CC; Ha, CS; Jagsi, R; Shumway, D; Daly, M; Wang, TJC; Fitzgerald, TJ; Laurie, F; Marshall, DT; Raben, D; Constine, L; Thomas, CR; Kachnic, LA, Clinical cancer research : an official journal of the American Association for Cancer Research
View All ResearchShow Less
  • The Impact of Academic Facility Type and Case Volume on Survival in Patients Undergoing Curative Radiation Therapy for Muscle-Invasive Bladder Cancer Bajaj, A.; Martin, B.; Bhasin, R.; Hentz, C.; Block, A. M.; Harkenrider, M. M.; Solanki, A. A., International journal of radiation oncology, biology, physics
  • Adjuvant Radiotherapy Use by US Radiation Oncologists After Radical Cystectomy for Muscle-invasive Bladder Cancer Solanki, A. A.; Martin, B.; Korpics, M.; Small, C.; Harkenrider, M. M.; Mitin, T., Clinical oncology (Royal College of Radiologists (Great Britain))
  • Adjuvant Radiotherapy Versus Wait-and-See Strategy for Pathologic T3 or Margin-Positive Prostate Cancer: A Meta-Analysis Shaikh, M. P.; Alite, F.; Wu, M. J.; Solanki, A. A.; Harkenrider, M. M., American Journal of Clinical Oncology
  • Bladder-Preserving Therapy Patterns of Care: A Survey of US Radiation Oncologists Solanki, A. A.; Martin, B.; Korpics, M.; Small, C.; Harkenrider, M. M.; Mitin, T., International journal of radiation oncology, biology, physics
  • Concurrent chemotherapy is associated with improved survival in elderly patients with bladder cancer undergoing radiotherapy Korpics, M. C.; Block, A. M.; Martin, B.; Hentz, C.; Gaynor, E. R.; Henry, E.; Harkenrider, M. M.; Solanki, A. A., Cancer
  • Cranial Base Meningiomas Prabhu, V. C.; Melian, E.; Germanwala, A. V.; Solanki, A. A.; Borys, E.; Barton, K.; Anderson, D. E., World neurosurgery
  • Observer Evaluation of a Metal Artifact Reduction Algorithm Applied to Head and Neck Cone Beam Computed Tomographic Images Korpics, M.; Surucu, M.; Mescioglu, I.; Alite, F.; Block, A. M.; Choi, M.; Emami, B.; Harkenrider, M. M.; Solanki, A. A.; Roeske, J. C., International journal of radiation oncology, biology, physics
  • Risk of second malignancies in patients with early-stage classical Hodgkin's lymphoma treated in a modern era. LeMieux, MH; Solanki, AA; Mahmood, U; Chmura, SJ; Koshy, M, Cancer medicine

Dr. Solanki's research focuses on advancing the treatment of patients with GU malignancies, brain and spine tumors, and metastases from cancer.

These interests include the treatment of prostate cancer with high-dose-rate (HDR) prostate brachytherapy, and in particular the role of brachytherapy in patients with newly diagnosed prostate cancer and those who have failed standard external beam radiotherapy. Additionally he is interested in the use of stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT) for spine and brain tumors.

Additionally, Dr. Solanki is interested in research identifying innovative methods to use modern information technologies to improve patient safety and quality in radiation oncology.